PRVA
Get informed when a big investor buys or sells
+ FollowUndervalued by 114% based on the discounted cash flow analysis.
| Market cap | $2.57 Billion |
|---|---|
| Enterprise Value | $-400,893,827,323.00 |
| Dividend Yield | $- (-) |
| Earnings per Share | $0.19 |
| Beta | 0.88 |
| Outstanding Shares | 126,121,426 |
| P/E Ratio | 90.8 |
|---|---|
| PEG | 38.35 |
| Price to Sales | 1.13 |
| Price to Book Ratio | 0.0 |
| Enterprise Value to Revenue | -170.01 |
| Enterprise Value to EBIT | -7634.04 |
| Enterprise Value to Net Income | -33 |
| Total Debt to Enterprise | -0.02 |
| Debt to Equity | 0.01 |
No data
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.00000% |
|---|---|
| Total Calls | 163,900▲ 43.65% |
| Total Puts | - |
Holdings and activity of institutional investors.
| Ownership % | 99.05%▲ 1.69% |
|---|---|
| Total Invested | $3.21B▲ 29.21% |
| Investors Holding | 305▲ 9.00% |
No data
Privia Health™ is a technology-driven, national physician enablement company that collaborates with medical groups, health plans, and health systems to optimize physician practices, improve patient experiences, and reward doctors for del...